Latest News about LGVN
Recent news which mentions LGVN
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 30, 2024
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 29, 2024
From Benzinga
Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying
January 03, 2024
From Benzinga
Nasdaq Gains 100 Points; CarMax Earnings Top Views
December 21, 2023
From Benzinga
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 21, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 21, 2023
From Benzinga
Crude Oil Moves Lower; Micron Issues Strong Forecast
December 21, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 20, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 05, 2023
From Benzinga
Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer's Disease with Lomecel-B™
December 05, 2023
Tickers
LGVN
From Benzinga
Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer's Disease with Lomecel-B™
December 05, 2023
Tickers
LGVN
From Benzinga
Earnings Scheduled For November 10, 2023
November 10, 2023
From Benzinga
Nearly A Third Of Japan's 36 Million Seniors Are At Risk Of Aging Frailty – Could Lomecel-BTM, Longeveron's (NASDAQ: LGVN) Cell Therapy Help?
October 23, 2023
Tickers
LGVN
From Benzinga
Does Bone Marrow Contain The Keys To Curing Alzheimer's? BioTech Announces Promising Results From Clinical Trial
October 13, 2023
Tickers
LGVN
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 12, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 09, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 09, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 06, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 05, 2023
From Benzinga
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 05, 2023
From Benzinga
Longeveron stock jumps on Alzheimer’s trial results
October 05, 2023
From MarketWatch
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 15, 2023
From Benzinga
Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved"
September 14, 2023
From Benzinga
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
September 11, 2023
From Benzinga
Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
September 06, 2023
From Benzinga
Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 31, 2023
From Benzinga
US Stocks Rise; Initial Jobless Claims Edge Lower
August 31, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.